https://pipelinereview.com/pfizer-announces-overall-survival-results-from-phase-3-paloma-3-trial-of-ibrance-palbociclib-in-hr-her2-metastatic-breast-cancer/
Pfizer Announces Overall Survival Results from Phase 3 PALOMA-3 Trial of IBRANCEĀ® (Palbociclib) in HR+, HER2- Metastatic Breast Cancer